About this FactMed analysis covering adverse side effect reports of LABETALOLHCL patients who developed DYSGEUSIA. FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, individuals taking LABETALOL reported TREATMENTNONCOMPLIANCE to the FDA. A total of 0 LABETALOLHCL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication. In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community – currently one million members and growing!
FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.